Quantitative high speed video analysis of biopolymer encapsulated cells while capsule formation

IFMBE Proceedings

Volumn 22, Issue , 2008, Pages 2255-2258

  Meiser, I ^a   Muller S C ^a   Gepp, M M ^a   Zimmermann, H ^a,b   Ehrhart, F ^a  

^a FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Alginates; Biopolymer; Cellbased therapy; Encapsulation; Transplant quality assurance

Indexed keywords

CAPSULE FORMATION; CELL-BASED THERAPY; CENTER OF GRAVITY; COMPUTER ASSISTED; DIABETES MELLITUS; DROPLET FORMATION; ENCAPSULATED CELL; ENCAPSULATED MATERIALS; EXTRACELLULAR; FRAMES PER SECONDS; HIGH-SPEED VIDEO; MATRIX; MECHANICAL STRESS; MICROCAPSULE FORMATION; ON-LINE EVALUATION; OPTIMIZATION PROCEDURES; POLYMERIZATION KINETICS; SHEAR FORCE; SINGLE CELLS; STATE OF THE ART; TRAJECTORY METHOD; TRANSPLANT PRODUCTION; VISCOELASTIC PROPERTIES;

BIOINFORMATICS; BIOMOLECULES; DEFORMATION; DISEASE CONTROL; DROP FORMATION; ENCAPSULATION; HIGH SPEED CAMERAS; HYDROGELS; QUALITY ASSURANCE; QUALITY CONTROL; STRESSES; TRAJECTORIES;

ALGINATE;

EID: 70350626818     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-540-89208-3_540     Document Type: Conference Paper

References (10)

1. Chang PL, Van Raamsdonk JM, Hortelano G, Barsoum SC, MacDonald NC, Stockley TL (1999) The in vivo delivery of heterologous proteins by microencapsulated recombinant cells. Trends Biotechnol 17:78-83
2. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC (2001) Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50:1698-1705
3. Dove A (2002) Cell-based therapies go live. Nat Biotechnol 20:339-343
4. Bartlett ST, Dirden B, Schweitzer EJ, Sheffield C, Hadley GA (1994) Prevention of recurrent autoimmune islet transplant destruction by simultaneous kidney transplantation. Transplant Proc 26:737
5. De Vos P, Van Straaten JF, Nieuwenhuizen AG, de Groot M, Ploeg RJ, De Haan BJ, Van Schilfgaarde R (1999) Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48:1381-1388
6. Orive G, Gascon AR, Hernandez RM, Igartua M, Luis Pedraz J (2003) Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends Pharmacol Sci 24:207-210
7. Orive G, Tam SK, Pedraz JL, Halle JP (2006) Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials 27:3691-3700
8. Zimmermann H, Shirley SG, Zimmermann U (2007) Alginate-based encapsulation of cells: past, present, and future. Curr Diab Rep 7:314-320
9. Zimmermann H, Zimmermann D, Reuss R, Feilen PJ, Manz B, Katsen A, Weber M, Ihmig FR, Ehrhart F, Gessner P, Behringer M, Steinbach A, Wegner LH, Sukhorukov VL, Vasquez JA, Schneider S, Weber MM, Volke F, Wolf R, Zimmermann U (2005) Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med 16:491-501
10. Meiser I, Shirley SG, Zimmermann H, Ehrhart F (2007) Quantitative High Speed Video Analysis to Embedding-Immobilization with Alginates. Proceedings Biomed Tech 52 ISSN 0939-4990